394 related articles for article (PubMed ID: 29427856)
1. New anticancer drug candidates sulfonamides as selective hCA IX or hCA XII inhibitors.
Gul HI; Yamali C; Sakagami H; Angeli A; Leitans J; Kazaks A; Tars K; Ozgun DO; Supuran CT
Bioorg Chem; 2018 Apr; 77():411-419. PubMed ID: 29427856
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological evaluation and in silico modelling studies of 1,3,5-trisubstituted pyrazoles carrying benzenesulfonamide as potential anticancer agents and selective cancer-associated hCA IX isoenzyme inhibitors.
Yamali C; Gul HI; Ece A; Bua S; Angeli A; Sakagami H; Sahin E; Supuran CT
Bioorg Chem; 2019 Nov; 92():103222. PubMed ID: 31499260
[TBL] [Abstract][Full Text] [Related]
3. Anticancer effects of new dibenzenesulfonamides by inducing apoptosis and autophagy pathways and their carbonic anhydrase inhibitory effects on hCA I, hCA II, hCA IX, hCA XII isoenzymes.
Gul HI; Yamali C; Bulbuller M; Kirmizibayrak PB; Gul M; Angeli A; Bua S; Supuran CT
Bioorg Chem; 2018 Aug; 78():290-297. PubMed ID: 29621641
[TBL] [Abstract][Full Text] [Related]
4. S-substituted 2-mercaptoquinazolin-4(3H)-one and 4-ethylbenzensulfonamides act as potent and selective human carbonic anhydrase IX and XII inhibitors.
El-Azab AS; Abdel-Aziz AA; Bua S; Nocentini A; AlSaif NA; Alanazi MM; El-Gendy MA; Ahmed HEA; Supuran CT
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):733-743. PubMed ID: 32189526
[TBL] [Abstract][Full Text] [Related]
5. Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: Selective inhibitors for the tumor-associated hCA IX isoform.
Ibrahim HS; Allam HA; Mahmoud WR; Bonardi A; Nocentini A; Gratteri P; Ibrahim ES; Abdel-Aziz HA; Supuran CT
Eur J Med Chem; 2018 May; 152():1-9. PubMed ID: 29684705
[TBL] [Abstract][Full Text] [Related]
6. Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies.
Żołnowska B; Sławiński J; Szafrański K; Angeli A; Supuran CT; Kawiak A; Wieczór M; Zielińska J; Bączek T; Bartoszewska S
Eur J Med Chem; 2018 Jan; 143():1931-1941. PubMed ID: 29146134
[TBL] [Abstract][Full Text] [Related]
7. Exploring of tumor-associated carbonic anhydrase isoenzyme IX and XII inhibitory effects and cytotoxicities of the novel N-aryl-1-(4-sulfamoylphenyl)-5-(thiophen-2-yl)-1H-pyrazole-3-carboxamides.
Yamali C; Inci Gul H; Ozli G; Angeli A; Ballar Kirmizibayrak P; Erbaykent Tepedelen B; Sakagami H; Bua S; Supuran CT
Bioorg Chem; 2021 Oct; 115():105194. PubMed ID: 34365059
[TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
Sławiński J; Szafrański K; Vullo D; Supuran CT
Eur J Med Chem; 2013 Nov; 69():701-10. PubMed ID: 24095761
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, biological activity and multiscale molecular modeling studies of bis-coumarins as selective carbonic anhydrase IX and XII inhibitors with effective cytotoxicity against hepatocellular carcinoma.
Kurt BZ; Dag A; Doğan B; Durdagi S; Angeli A; Nocentini A; Supuran CT; Sonmez F
Bioorg Chem; 2019 Jun; 87():838-850. PubMed ID: 31003041
[TBL] [Abstract][Full Text] [Related]
10. Novel benzofuran-based sulphonamides as selective carbonic anhydrases IX and XII inhibitors: synthesis and
Abdelrahman MA; Eldehna WM; Nocentini A; Ibrahim HS; Almahli H; Abdel-Aziz HA; Abou-Seri SM; Supuran CT
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):298-305. PubMed ID: 31809607
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive study on potent and selective carbonic anhydrase inhibitors: Synthesis, bioactivities and molecular modelling studies of 4-(3-(2-arylidenehydrazine-1-carbonyl)-5-(thiophen-2-yl)-1H-pyrazole-1-yl) benzenesulfonamides.
Yamali C; Sakagami H; Uesawa Y; Kurosaki K; Satoh K; Masuda Y; Yokose S; Ece A; Bua S; Angeli A; Supuran CT; Gul HI
Eur J Med Chem; 2021 May; 217():113351. PubMed ID: 33744685
[TBL] [Abstract][Full Text] [Related]
12. Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors.
Ramya PVS; Angapelly S; Angeli A; Digwal CS; Arifuddin M; Babu BN; Supuran CT; Kamal A
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1274-1281. PubMed ID: 28965419
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT
Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567
[TBL] [Abstract][Full Text] [Related]
14. Novel sulfonamide bearing coumarin scaffolds as selective inhibitors of tumor associated carbonic anhydrase isoforms IX and XII.
Chandak N; Ceruso M; Supuran CT; Sharma PK
Bioorg Med Chem; 2016 Jul; 24(13):2882-2886. PubMed ID: 27137360
[TBL] [Abstract][Full Text] [Related]
15. Insertion of metal carbenes into the anilinic N-H bond of unprotected aminobenzenesulfonamides delivers low nanomolar inhibitors of human carbonic anhydrase IX and XII isoforms.
Sharonova T; Paramonova P; Kalinin S; Bunev A; Gasanov RЕ; Nocentini A; Sharoyko V; Tennikova TB; Dar'in D; Supuran CT; Krasavin M
Eur J Med Chem; 2021 Jun; 218():113352. PubMed ID: 33774343
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of coumarin-sulfonamide derivatives and determination of their cytotoxicity, carbonic anhydrase inhibitory and molecular docking studies.
Zengin Kurt B; Sonmez F; Ozturk D; Akdemir A; Angeli A; Supuran CT
Eur J Med Chem; 2019 Dec; 183():111702. PubMed ID: 31542715
[TBL] [Abstract][Full Text] [Related]
17. The three-tails approach as a new strategy to improve selectivity of action of sulphonamide inhibitors against tumour-associated carbonic anhydrase IX and XII.
Bonardi A; Bua S; Combs J; Lomelino C; Andring J; Osman SM; Toti A; Di Cesare Mannelli L; Gratteri P; Ghelardini C; McKenna R; Nocentini A; Supuran CT
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):930-939. PubMed ID: 35306936
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase inhibitors. Synthesis of 2,4,6-trimethylpyridinium derivatives of 2-(hydrazinocarbonyl)-3-aryl-1H-indole-5-sulfonamides acting as potent inhibitors of the tumor-associated isoform IX and XII.
Güzel O; Maresca A; Scozzafava A; Salman A; Balaban AT; Supuran CT
Bioorg Med Chem Lett; 2009 Jun; 19(11):2931-4. PubMed ID: 19410461
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of novel 4,7-disubstituted coumarins as selective tumor-associated carbonic anhydrase IX and XII inhibitors.
Chandra KM; Goud NS; Arifuddin M; Alvala M; Alvala R; Angeli A; Supuran CT
Bioorg Med Chem Lett; 2021 May; 39():127877. PubMed ID: 33640442
[TBL] [Abstract][Full Text] [Related]
20. Isatin-pyrazole benzenesulfonamide hybrids potently inhibit tumor-associated carbonic anhydrase isoforms IX and XII.
Ibrahim HS; Abou-Seri SM; Tanc M; Elaasser MM; Abdel-Aziz HA; Supuran CT
Eur J Med Chem; 2015 Oct; 103():583-93. PubMed ID: 26408817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
